Skip to content

Efficacy and economic evaluation of antimicrobial prophylaxis in EMR or ESD of colorectum

Efficacy and economic evaluation of antimicrobial prophylaxis in EMR or ESD of colorectum

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007613
Enrollment
Unknown
Registered
2015-12-18
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The tumor of colorectum

Interventions

two :the usage of cefotiam
control group:normal saline

Sponsors

Fuzhou General Hospital of Nanjing Military
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) The colorectal tumor patients who need to under EMR or ESD, such as EMR, the tumor is more than 10mm*10mm; 2) The patients without other major diseases such as severe heart and lung disease, liver and kidney failure, etc., the recent usage of drugs such as antibiotics in one week ago; 3) The coagulation time was normal; 4) To comply with the ethical.

Exclusion criteria

Exclusion criteria: 1) The patients who have blood system disease, a blood coagulative disorder, the recent use of anticoagulant drugs; 2) Patients who have malignant tumors under the mucous membrane; 3) Bowel preparation poor; 4) The patients who would not cooperate and refuse to participate in the trial; 5) Allergic the drug; 6) The patients whose situation suddenly change or aggravation during the therapy.

Design outcomes

Primary

MeasureTime frame
age;gender;the method of surgery;the size of the tumor;the location of the tumor;the morphology of the tumor;white blood cell;neutrophile cell;erythrocyte sedimentation rate (ESR);C-reactive protein;blood culture;body temperature;stomachache;diarrhea;hematochezia;perforation;the cost of hospitalization;Lenth of hospitalization;interleukin-1;interleukin-6;

Countries

China

Contacts

Public ContactWang Wen
wangw68@medmail.com.cn+86 13860628134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026